These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25917785)

  • 1. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
    Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
    Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost effectiveness of radiofrequency ablation for Barrett's esophagus.
    Hur C; Choi SE; Rubenstein JH; Kong CY; Nishioka NS; Provenzale DT; Inadomi JM
    Gastroenterology; 2012 Sep; 143(3):567-575. PubMed ID: 22626608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett's Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis.
    Klair JS; Zafar Y; Nagra N; Murali AR; Jayaraj M; Singh D; Rustagi T; Krishnamoorthi R
    Dig Dis; 2021; 39(6):561-568. PubMed ID: 33503615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.
    Duits LC; van der Wel MJ; Cotton CC; Phoa KN; Ten Kate FJW; Seldenrijk CA; Offerhaus GJA; Visser M; Meijer SL; Mallant-Hent RC; Krishnadath KK; Pouw RE; Tijssen JGP; Shaheen NJ; Bergman JJGHM
    Gastroenterology; 2017 Apr; 152(5):993-1001.e1. PubMed ID: 28012849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett's Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials.
    Wang Y; Ma B; Yang S; Li W; Li P
    Front Oncol; 2022; 12():801940. PubMed ID: 35296005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
    Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
    Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus.
    Nayna L; Emma W; Vani K
    Curr Opin Gastroenterol; 2016 Jul; 32(4):294-301. PubMed ID: 27070914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.
    Wolf WA; Pasricha S; Cotton C; Li N; Triadafilopoulos G; Muthusamy VR; Chmielewski GW; Corbett FS; Camara DS; Lightdale CJ; Wolfsen H; Chang KJ; Overholt BF; Pruitt RE; Ertan A; Komanduri S; Infantolino A; Rothstein RI; Shaheen NJ
    Gastroenterology; 2015 Dec; 149(7):1752-1761.e1. PubMed ID: 26327132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis.
    Qumseya BJ; Wani S; Gendy S; Harnke B; Bergman JJ; Wolfsen H
    Am J Gastroenterol; 2017 Jun; 112(6):849-865. PubMed ID: 28374819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.
    Phoa KN; van Vilsteren FG; Weusten BL; Bisschops R; Schoon EJ; Ragunath K; Fullarton G; Di Pietro M; Ravi N; Visser M; Offerhaus GJ; Seldenrijk CA; Meijer SL; ten Kate FJ; Tijssen JG; Bergman JJ
    JAMA; 2014 Mar; 311(12):1209-17. PubMed ID: 24668102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
    Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
    Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
    Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
    Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial.
    Pouw RE; Klaver E; Phoa KN; van Vilsteren FG; Weusten BL; Bisschops R; Schoon EJ; Pech O; Manner H; Ragunath K; Fernández-Sordo JO; Fullarton G; Di Pietro M; Januszewicz W; O'Toole D; Bergman JJ
    Gastrointest Endosc; 2020 Sep; 92(3):569-574. PubMed ID: 32217112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radio frequency ablation of dysplastic Barrett's esophagus: Outcomes of a single-center registry.
    Mathiesen M; Holm J; Thorsteinsson M
    Scand J Surg; 2023 Jun; 112(2):86-90. PubMed ID: 36756673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of lesions in dysplastic Barrett's esophagus by community and expert endoscopists.
    Schölvinck DW; van der Meulen K; Bergman JJGHM; Weusten BLAM
    Endoscopy; 2017 Feb; 49(2):113-120. PubMed ID: 27855466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.